Variant report
Variant | esv3333102 |
---|---|
Chromosome Location | chr4:93503529-93506927 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556127154 | chr4:93503586-93503587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191087564 | chr4:93503627-93503628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544805906 | chr4:93503657-93503658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558643411 | chr4:93503674-93503675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115924415 | chr4:93503742-93503743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540637019 | chr4:93503808-93503809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374258619 | chr4:93503837-93503838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561196662 | chr4:93503868-93503869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62310102 | chr4:93503902-93503903 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs543599524 | chr4:93503982-93503983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62310103 | chr4:93504002-93504003 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs532614983 | chr4:93504015-93504016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs62310104 | chr4:93504044-93504045 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs566180713 | chr4:93504061-93504062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143100529 | chr4:93504073-93504074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548650337 | chr4:93504086-93504087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62310105 | chr4:93504094-93504095 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs536585824 | chr4:93504095-93504096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556302912 | chr4:93504110-93504111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569725474 | chr4:93504141-93504142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538845427 | chr4:93504143-93504144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558630051 | chr4:93504144-93504145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9685970 | chr4:93504230-93504231 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs112739203 | chr4:93504260-93504261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541275260 | chr4:93504301-93504302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534311955 | chr4:93504319-93504320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554182153 | chr4:93504373-93504374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148219243 | chr4:93504417-93504418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs34845420 | chr4:93504457-93504458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11303889 | chr4:93504500-93504501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564030346 | chr4:93504521-93504522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577331583 | chr4:93504523-93504524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546387529 | chr4:93504529-93504530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs72882149 | chr4:93504570-93504571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528638025 | chr4:93504600-93504601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548588966 | chr4:93504616-93504617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9684124 | chr4:93504643-93504644 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs185268036 | chr4:93504688-93504689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549774777 | chr4:93504774-93504775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201623504 | chr4:93504777-93504778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76911864 | chr4:93504807-93504808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146500293 | chr4:93504808-93504809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs398063810 | chr4:93504819-93504820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs62310106 | chr4:93504821-93504822 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs200241015 | chr4:93504854-93504855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs70942912 | chr4:93504856-93504857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34130390 | chr4:93504857-93504858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs397729257 | chr4:93504864-93504865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78945563 | chr4:93504867-93504868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs183207905 | chr4:93504871-93504872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:93495600-93511400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr4:93495600-93535600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr4:93496400-93540200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr4:93497800-93511200 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr4:93497800-93524200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr4:93498000-93521800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr4:93501800-93504200 | Weak transcription | Brain Anterior Caudate | brain |
8 | chr4:93502800-93531400 | Weak transcription | H9 Cell Line | embryonic stem cell |
9 | chr4:93503000-93504800 | Enhancers | Brain Substantia Nigra | brain |
10 | chr4:93503200-93503600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
11 | chr4:93503600-93505400 | Enhancers | Brain Inferior Temporal Lobe | brain |
12 | chr4:93504200-93504600 | Enhancers | Brain Anterior Caudate | brain |
13 | chr4:93504400-93504600 | Enhancers | Brain Angular Gyrus | brain |